首页> 美国卫生研究院文献>AIMS Microbiology >An overview of the antimicrobial resistance mechanisms of bacteria
【2h】

An overview of the antimicrobial resistance mechanisms of bacteria

机译:细菌的抗药性机制概述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Resistance to antimicrobial agents has become a major source of morbidity and mortality worldwide. When antibiotics were first introduced in the 1900's, it was thought that we had won the war against microorganisms. It was soon discovered however, that the microorganisms were capable of developing resistance to any of the drugs that were used. Apparently most pathogenic microorganisms have the capability of developing resistance to at least some antimicrobial agents. The main mechanisms of resistance are: limiting uptake of a drug, modification of a drug target, inactivation of a drug, and active efflux of a drug. These mechanisms may be native to the microorganisms, or acquired from other microorganisms. Understanding more about these mechanisms should hopefully lead to better treatment options for infective diseases, and development of antimicrobial drugs that can withstand the microorganisms attempts to become resistant.
机译:对抗菌剂的耐药性已成为全世界发病率和死亡率的主要来源。在1900年代首次引入抗生素时,人们认为我们赢得了抗微生物战争。然而,很快发现,微生物能够对使用的任何药物产生抗药性。显然,大多数病原微生物具有对至少一些抗微生物剂产生抗性的能力。抗药性的主要机制是:限制药物的摄取,修饰药物靶标,使药物失活以及药物的主动流出。这些机制可能是微生物固有的,也可能是其他微生物获得的。希望更多地了解这些机制,有望为传染病带来更好的治疗选择,并开发出可以抵抗微生物的抗微生物药物,从而使其具有抗药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号